Monday, December 16, 2013
Sunday, December 15, 2013
As Introduced
|
|
Senator Burke
Cosponsors: Senators Brown, Gardner
To memorialize the Congress of the United States to seek the withdrawal of the United States Preventive Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups. |
BE IT RESOLVED BY THE SENATE OF THE STATE OF OHIO
(THE HOUSE OF REPRESENTATIVES CONCURRING):
WHEREAS, The United States Preventive Services Task Force (USPSTF) is an independent panel of nonfederal experts in prevention and evidence-based medicine that is composed of primary care physicians; and |
WHEREAS, The USPSTF members are appointed by the United States Department of Health and Human Services to conduct scientific evidence reviews of a broad range of clinical health care preventive services and develop recommendations for primary care clinicians and health systems; and |
WHEREAS, The USPSTF acknowledges that prostate cancer is the most commonly diagnosed nonskin cancer in men in the United States, with one in six American men being diagnosed with prostate cancer in his lifetime; and |
WHEREAS, Prostate cancer is the second leading cause of cancer-related deaths in men in the United States; and |
WHEREAS, The American Cancer Society estimates that in 2013 approximately 238,590 men in the United States will be diagnosed with prostate cancer and 29,720 men will die from the disease; and |
WHEREAS, In Ohio alone, there are approximately 7,961 newly diagnosed cases of prostate cancer and 1,232 deaths from the disease on an annual basis, according to the February 2011 report issued by the Ohio Cancer Incidence Surveillance System; and |
WHEREAS, In 2008, the USPSTF recommended against prostate-specific antigen-based screening for prostate cancer for men ages 75 and older; and |
WHEREAS, In October 2011, the USPSTF issued a new recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups, because it concluded that there is moderate or high certainty that the service has no net benefit or that the harms outweigh the benefits; and |
WHEREAS, The USPSTF states that the October 2011 recommendation applies to men in the United States who do not have symptoms of prostate cancer, even though by the time a man experiences symptoms of prostate cancer, the cancer is generally too advanced to cure; and |
WHEREAS, The USPSTF states that its recommendation against screening applies regardless of race, even though the USPSTF acknowledges that African-American men have a substantially higher prostate cancer incidence rate than Caucasian men and more than twice the prostate cancer mortality rate of Caucasian men; and |
WHEREAS, The USPSTF issued this recommendation without having a urologist or oncologist, two types of physicians who specialize in diagnosing and treating patients with prostate cancer, on the task force; and |
WHEREAS, The USPSTF's 2011 recommendation regarding prostate cancer screening follows its recommendation in November 2009 against routine mammograms for women ages 40 to 49 and against teaching women to do breast self-examinations, which Congress rejected after public outcry; and |
WHEREAS, The most recently updated study, the Goteborg Randomized Population-based Prostate Cancer Screening Trial, found that with screening, deaths from prostate cancer dropped 44 per cent over a 14-year period, compared with men who did not undergo screening, and that prostate cancer screening efficiency was similar to other cancers; and |
WHEREAS, The USPSTF recommendation against screening puts into harm's way men who are most at risk: the underinsured, those who live in areas where health care is not readily available, those who have a family history of prostate cancer, and African-American men, who have a higher incidence of and higher mortality rate from prostate cancer than Caucasian men; now therefore be it |
RESOLVED, That we, the members of the 130th General Assembly of the State of Ohio, in adopting this resolution, respectfully memorialize the Congress of the United States to seek the withdrawal of the United States Preventive Services Task Force recommendation against prostate-specific antigen-based screening for prostate cancer for men in all age groups; and be it further |
RESOLVED, That the Clerk of the Senate transmit duly authenticated copies of this resolution to each member of the Ohio Congressional delegation. |
Status Report of Legislation
130th General Assembly - Senate Concurrent
Resolutions
Primary Sponsor(s): Burke
|
|
Subject: Prostate cancer antigen-based screening- withdraw
recommendation against
|
|
Abbreviations used in the Status
Report
|
||||
A - Amended
|
P - Postponed
|
S - Substitute
|
* - Note
|
|
F - Failed to Pass
|
R - Rereferred
|
V - Vetoed
|
Action by Chamber
|
Senate
|
House
|
||
Introduced
|
03/19/13
|
12/10/13
|
||
Committee Assigned
|
Medicaid, Health &
Human Services
|
Health and Aging
|
||
Committee Report
|
11/20/13
|
|||
Passed 3rd
Consideration
|
12/04/13
|
|||
Further Action
|
||||
To Conference
Committee
|
||||
Concurrence
|
||||
Sent to Governor
|
||||
End of 10-day period
|
||||
Governor's Action
|
||||
Effective Date
|
||||
As Adopted by the Senate
|
|
Senator Burke
Cosponsors: Senators Brown, Gardner,
Tavares, Bacon, Balderson, Beagle, Coley, Eklund, Faber, Hite, Hughes, Jones,
Kearney, LaRose, Lehner, Manning, Obhof, Oelslager, Patton, Peterson, Sawyer,
Schaffer, Seitz, Skindell, Smith, Uecker, Widener
A CONCURRENT RESOLUTION
To memorialize the Congress of the
United States to seek the withdrawal of the United States Preventive Services
Task Force recommendation against prostate-specific antigen-based screening
for prostate cancer for men in all age groups.
|
BE IT RESOLVED BY THE SENATE OF THE STATE OF OHIO
(THE HOUSE OF REPRESENTATIVES CONCURRING):
WHEREAS,
The United States Preventive Services Task Force (USPSTF) is an independent
panel of nonfederal experts in prevention and evidence-based medicine that is
composed of primary care physicians; and
|
WHEREAS,
The USPSTF members are appointed by the United States Department of Health
and Human Services to conduct scientific evidence reviews of a broad range of
clinical health care preventive services and develop recommendations for
primary care clinicians and health systems; and
|
WHEREAS,
The USPSTF acknowledges that prostate cancer is the most commonly diagnosed
nonskin cancer in men in the United States, with one in six American men
being diagnosed with prostate cancer in his lifetime; and
|
WHEREAS,
Prostate cancer is the second leading cause of cancer-related deaths in men
in the United States; and
|
WHEREAS,
The American Cancer Society estimates that in 2013 approximately 238,590 men
in the United States will be diagnosed with prostate cancer and 29,720 men
will die from the disease; and
|
WHEREAS,
In Ohio alone, there are approximately 7,961 newly diagnosed cases of
prostate cancer and 1,232 deaths from the disease on an annual basis,
according to the February 2011 report issued by the Ohio Cancer Incidence
Surveillance System; and
|
WHEREAS,
In 2008, the USPSTF recommended against prostate-specific antigen-based
screening for prostate cancer for men ages 75 and older; and
|
WHEREAS,
In October 2011, the USPSTF issued a new recommendation against
prostate-specific antigen-based screening for prostate cancer for men in all
age groups, because it concluded that there is moderate or high certainty
that the service has no net benefit or that the harms outweigh the benefits;
and
|
WHEREAS,
The USPSTF states that the October 2011 recommendation applies to men in the
United States who do not have symptoms of prostate cancer, even though by the
time a man experiences symptoms of prostate cancer, the cancer is generally
too advanced to cure; and
|
WHEREAS,
The USPSTF states that its recommendation against screening applies
regardless of race, even though the USPSTF acknowledges that African-American
men have a substantially higher prostate cancer incidence rate than Caucasian
men and more than twice the prostate cancer mortality rate of Caucasian men;
and
|
WHEREAS,
The USPSTF issued this recommendation without having a urologist or
oncologist, two types of physicians who specialize in diagnosing and treating
patients with prostate cancer, on the task force; and
|
WHEREAS,
The USPSTF's 2011 recommendation regarding prostate cancer screening follows
its recommendation in November 2009 against routine mammograms for women ages
40 to 49 and against teaching women to do breast self-examinations, which
Congress rejected after public outcry; and
|
WHEREAS,
The most recently updated study, the Goteborg Randomized Population-based
Prostate Cancer Screening Trial, found that with screening, deaths from
prostate cancer dropped 44 per cent over a 14-year period, compared with men
who did not undergo screening, and that prostate cancer screening efficiency
was similar to other cancers; and
|
WHEREAS,
The USPSTF recommendation against screening puts into harm's way men who are
most at risk: the underinsured, those who live in areas where health care is
not readily available, those who have a family history of prostate cancer,
and African-American men, who have a higher incidence of and higher mortality
rate from prostate cancer than Caucasian men; now therefore be it
|
RESOLVED,
That we, the members of the 130th General Assembly of the State of Ohio, in
adopting this resolution, respectfully memorialize the Congress of the United
States to seek the withdrawal of the United States Preventive Services Task
Force recommendation against prostate-specific antigen-based screening for
prostate cancer for men in all age groups; and be it further
|
RESOLVED,
That the Clerk of the Senate transmit duly authenticated copies of this
resolution to each member of the Ohio Congressional delegation.
|
Thursday, December 12, 2013
Tuesday, December 3, 2013
Monday, December 2, 2013
Sunday, December 1, 2013
Subscribe to:
Posts (Atom)